The eagerly anticipated annual campaign Hypo Awareness Week returns this October, with the aim of raising crucial awareness of hypoglycaemia among healthcare professionals in the UK and Ireland.

Diabetes inpatient teams across England are being urged to take part in a GIRFT survey to help create a snapshot of current service provision.

Research into the outcomes for people admitted with diabetic foot ulcer to hospitals which serve an ethnically diverse population has revealed the high amputation risk – 44 per cent – among its mostly Black and/or Hispanic patients.

The use of sodium-glucose cotransporter-2 inhibitors was linked with lower risk of acute kidney injury for people with type 2 diabetes and stage five chronic kidney disease, research claims.

New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D), published today in Diabetes Care and Diabetologia, has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.

The DAFNE (Dose Adjustment for Normal Eating) programme is excited to announce two new free online learning opportunities designed specifically for diabetes healthcare professionals who are not part of a DAFNE service.

The Committee for Medicine Products for Human Use (CHMP) has recommended granting marketing authorisation for Zegalogue for the treatment of severe hypoglycaemia in people with diabetes.

A top guideline on how to use technology to support diabetes care in hospital has been updated.

The Diabetes Specialist Nurse (DSN) Forum UK has raised more than £3,000 to enable healthcare teams in Sierra Leone to buy lifesaving diabetes resources.

Latest research shows an injection developed to tackle obesity cuts the risk of heart attacks and strokes, regardless of the amount of weight lost.

A survey is being conducted looking at the diagnosis of osteomyelitis in people with diabetes and a foot ulcer.

CamDiab has received authorisation from The Food and Drug Administration (FDA) in the US for its advanced adaptive hybrid closed-loop app, CamAPS FX, as an ‘interoperable automated glycaemic controller device’ (iAGC).

As part of the buildup to Insulin Safety Week 2024, a recent webinar proved a resounding success, attracting healthcare professionals from across the UK and Ireland to increase their understanding of the latest advancements in diabetes technology.

Diabetes specialist nurses are invited to join the Diabetes UK Professional Conference organising committee ahead of next year’s event.

A diabetes steering committee has developed a SGLT2 inhibitors prescribing decision tool to provide healthcare professionals with a quick summary on the changing product licenses, guideline recommendations and new data on this class of drugs.

Healthcare professionals are encouraged to book their place on a free educational webinar in the run up to Insulin Safety Week 2024.

DISN UK Group announce the first dates for their inaugural roadshow, promising an educational and informative diabetes event for healthcare professionals.